XTalks

FEBRUARY 8, 2024

Diabetes remains a critical global challenge, affecting millions of lives and commanding significant attention from the medical, life sciences and pharmaceutical sectors. Understanding the market dynamics of diabetes treatments becomes crucial for professionals across these industries. Outside the US, revenue was $409.8

Sales 52

Sales Insulin FDA Approval Drugs 52

pharmaphorum

JUNE 9, 2022

million 1 people per year and projected to rise to 10 million people by 2050 2. In its Strategic Priorities on AMR , the WHO made clear that “unless we act now, common diseases will become untreatable and modern life-saving procedures riskier to perform” as AMR proliferates.

Bacteria 98

Bacteria Development In-Vitro Drugs 98

pharmaphorum

MAY 23, 2022

Alliances have proven to be significant catalysts for change in regions of the world where digital health is either needed or in need of expansion. million of US government funding, specifically for digital connectivity infrastructure and digital financial services. Collaborative results. Pharma’s role.

Development 89

Development Life Science Production Manufacturing 89

Pfizer

FEBRUARY 9, 2023

After chickenpox, the virus remains dormant in human nerve cells and can reactivate later in life due to stress or immunosuppression. 7 Furthermore, both the incidence and severity of shingles rise with age, with a marked increase after age 50. For more than 170 years, we have worked to make a difference for all who rely on us.

Vaccination 75

Vaccination Vaccine Clinical Trials Clinical Trials 75

The Pharma Data

MARCH 31, 2023

NASDAQ: SCYX), today announced they have entered into an exclusive licence agreement for Brexafemme (ibrexafungerp tablets), a US FDA approved, first-in-class antifungal for the treatment of vulvovaginal candidiasis (VVC) and for reduction in the incidence of recurrent VVC (RVVC). David Angulo, M.D., David Angulo, M.D.,

Medicine 40

Medicine Development FDA Approval Sales 40

Drug Discovery World

MARCH 6, 2024

The prevalence of these diseases has grown substantially in recent decades due to an increasing global population, longer life expectancies and increasing morbidity with predisposing risk factors. They also involve multiple mutations in non-coding regions of DNA – the ‘dark genome’ which makes up around 98% of our DNA.

Genome 64

Genome Genomics Clinical Trials Clinical Trials 64

Drug Discovery World

SEPTEMBER 16, 2022

The knowledge base and applied science is cutting edge and ahead of the field, although we anticipate there will be additional interest arising particularly in the US, as this is a very active area to watch. Unsurprisingly, the US is currently the biggest market in the world for cell and gene therapies. The company’s latest $44.5m

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

XTalks

JUNE 12, 2023

Join us as we explore the inspiring journey and significant contributions of these top 10 medical device companies. dollars utilizes the average annual exchange rates reported by the US Internal Revenue Service (IRS). dollars utilizes the average annual exchange rates reported by the US Internal Revenue Service (IRS).

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

XTalks

AUGUST 2, 2023

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 billion, a 42.74

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

SEPTEMBER 22, 2021

Working in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences. If commitment to the HIV response wanes, the progress we have made is at risk, leading to increases in new infections in regions that can least afford to tackle them. “An We all have one common goal: ending HIV”.

Development 68

Development Drugs 68

Pharmaceutical Technology

DECEMBER 19, 2022

Last week, the US Federal Reserve raised interest rates for the seventh time this year in a continuing bid to stave off worries of a recession. The International Monetary Fund predicts that real gross domestic product (GDP) growth in the US will fall from 1.6% JP Morgan predicts that the US unemployment rate could rise to 4.3%

Life Science 173

Life Science Manufacturing Medicine Production 173

XTalks

SEPTEMBER 14, 2020

These companies include Moderna, a US biotech company which has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID), Oxford University who has partnered with AstraZeneca, and Johnson & Johnson, Merck and Pfizer. Pfizer and BioNTech’s COVID-19 Vaccine.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92